• Select Article Type
  • Abstract Supplements
  • Blood Group Review
  • Call to Arms
  • Communications
  • Hypothesis
  • In Memoriam
  • Interview
  • Introduction
  • Letter to the Editor
  • Short Report
  • abstract
  • Abstracts
  • Article
  • book-review
  • case-report
  • case-study
  • Clinical Practice
  • Commentary
  • Conference Presentation
  • conference-report
  • congress-report
  • Correction
  • critical-appraisal
  • Editorial
  • Editorial Comment
  • Erratum
  • Events
  • in-memomoriam
  • Letter
  • Letter to Editor
  • mini-review
  • minireview
  • News
  • non-scientific
  • Obituary
  • original-paper
  • original-report
  • Original Research
  • Pictorial Review
  • Position Paper
  • Practice Report
  • Preface
  • Preliminary report
  • Product Review
  • rapid-communication
  • Report
  • research-article
  • Research Communicate
  • research-paper
  • Research Report
  • Review
  • review -article
  • review-article
  • review-paper
  • Review Paper
  • Sampling Methods
  • Scientific Commentary
  • serologic-method-review
  • short-communication
  • short-report
  • Student Essay
  • Varia
  • Welome
  • Select Journal
  • Immunohematology


Article | 17-February-2021

An outcome-based review of an accredited Specialist in Blood Banking (SBB) program: 25 years and counting

and Guidelines adopted by the AABB and CAAHEP.2 To ensure meeting these rules, inspectors representing AABB and CAAHEP assess SBB programs on a routine basis. The curriculum must adhere to the Standards and Guidelines, and each SBB program then develops teaching methods that address the three domains of learning and provides evidence of competency by students.2 On an annual basis, each program is required to complete and submit a report to the accrediting body.1 This report is outcome-based

K.M. Byrne, T.D. Paige, W.A. Flegel

Immunohematology, Volume 36 , ISSUE 1, 7–13

Editorial | 27-December-2020

Congratulations AABB awards - 1989

Mary McGinniss

Immunohematology, Volume 5 , ISSUE 4, 125–126

Letter | 27-December-2020

Letter from the Editor: Exhibit at AABB

Delores Mallory

Immunohematology, Volume 5 , ISSUE 3, 92–92

Case report | 14-October-2020

Discrepancies in Rh(D) typing of sensitized red blood cells using monoclonal/polyclonal anti-D reagents: case report and review

Instructions included with monoclonal Rh(D) typing reagents do not require routine use of an Rh control as immunoglobulin-coated red blood cells (RBCs) rarely yield falsely positive results with low protein reagents. However, the American Association of Blood Banks (AABB) Technical Manual recommends a concurrent control be performed on patients’ RBCs that type as group AB, D+. Proficiency testing surveys presented sensitized AB, D– RBCs, which resulted in a positive direct

Beverly J. Padget, Judith L. Hannon

Immunohematology, Volume 17 , ISSUE 1, 10–13

Article | 14-December-2020

The sensitivity of antibody detection testing using pooled versus unpooled reagent red cells

Because the sensitivity of antibody detection testing may be reduced when pooled reagent red blood cells (RBCs) are used, the American Association of Blood Banks (AABB) prohibits the use of pooled reagent RBCs when performing pretransfusion antibody detection testing. This restriction imposed upon the use of pooled reagent RBCs is based, at least in part, on the belief that pooled reagent RBCs are less likely to detect clinically significant antibodies than are sets of unpooled reagent RBCs

Ira A. Shulman, Roland Nakayama, Cintia Calderon

Immunohematology, Volume 7 , ISSUE 1, 16–19

Report | 01-December-2019

Cryopreservation of red blood cell units with a modified method of glycerolization and deglycerolization with the ACP 215 device complies with American and European requirements

percent for AS3-preserved RBCs and 0.25 ± 0.08 percent for RBCs preserved with SAG-M. On expiration, 32 percent of initial ATP values were measured in AS3-preserved RBCs vs. 62 percent in SAG-M–preserved RBCs. This modified method of glycerolization and deglycerolization meets the quality requirements of the European Council and the AABB standards. The prolonged storage of thawed RBCs enables optimized transfusion management for patients with rare blood groups.

Jana List, Michaela Horvath, Gerda C. Leitner, Günter Weigel

Immunohematology, Volume 28 , ISSUE 2, 67–73

Report | 12-March-2020

Determination of optimal method for antibody identification in a reference laboratory

Methods commonly used for antibody identification are hemagglutination (tube), column agglutination (gel), and solid-phase red cell adherence. Our AABB immunohematology reference laboratory (IRL) conducted a study to determine which antibody identification testing method was optimal for detecting all clinically significant antibodies. Patient specimens were sent to our IRL from August 2008 to September 2009. Routine testing was performed by tube method and then by manual gel and manual solid

Jennifer R. Haywood, Marilyn K. Grandstaff Moulds, Barbara J. Bryant

Immunohematology, Volume 27 , ISSUE 4, 146–150

original-report | 30-November-2020

New ABO intron 1 variant alleles

K. Fennell, M.A. Keller, M.A. Villa, C. Paccapelo, M. Kucerakova, J. Rosochova, C. Clemente DosSantos, L. Brackney, C.J. Lee, R. Metcalf, G. Crovetti, M. Barbieri, S. Travali, G. Barrotta, G. Giuca, L.E. Guerra, G. Ochoa-Garay

Immunohematology, Volume 37 , ISSUE 4, 178–184

Report | 20-March-2020

Cost-effectiveness of FDA variance for blood collection from individuals with hereditary hemochromatosis at a 398-bed hospitalbased donor center

Hereditary hemochromatosis (HH) is treated by therapeutic phlebotomy to reduce excess body iron. This 398-bed, hospital-based donor center wanted to determine whether there was a financial advantage to requesting FDA approval to allow transfusion of blood components from eligible individuals with HH. Donor center records from 2008 were reviewed to identify all therapeutic phlebotomy patients with a diagnosis of HH. HH patients were contacted and asked to complete the AABB Uniform Donor History

Dee M. Gribble, DJ Chaffin, Barbara J. Bryant

Immunohematology, Volume 25 , ISSUE 4, 170–173

Article | 29-December-2020

Assessing the clinical significance of anti-Cra and anti-M in a chronically transfused sickle cell patient

Banks (AABB) failed to identify Cr(a -), M-, E-, K -, S -, Fy(a - b -) donors. Various studies were performed to pre­dict the clinical significance of the anti-Cra and anti-M. Results of 51chromium survival studies showed 91.8 percent survival at 10 minutes and 87.2 percent survival at 60 minutes with Cr(a +), M -, E -, K -, S -, Fy(a - b -) red cells, suggesting that immediate de­struction of transfused Cr(a +) red cells would be unlikely. How­ever, further analysis revealed diminished

Mary B. Leatherbarrow, Sandra S. Ellisor, Patricia A. Collins, Deborah K. Douglas, Robert J. Eckrich, Susan S. Esty, Michael L. Baldwin, Paul M. Ness

Immunohematology, Volume 4 , ISSUE 4, 71–74

No Record Found..
Page Actions